NextGen Clinical Trial Innovation | Virtual Summit

Memo

As the industry continues to learn, innovate and continues to march forward with its adoption of a decentralized model, it is critical to continue evolving the technology. By applying a strategic approach to innovation, you can discern and leverage the necessary and beneficial shifts for the next generation of clinical trials. The mission is to provide attendees with the necessary innovative tools to tackle the most frequently identified reasons for trial failure such as study design, diversity in clinical trials, site selection, inadequate recruitment, patient burden or safety issues, and share best practices on how to conduct a high level of trial design and management to ensure cost-effective use of time and budgetary resources so that targets are met without compromising data integrity and regulatory compliance. Our expert speaking faculty will address the opportunities for using digital biomarkers, remote healthcare, including conducting virtual or decentralized trials in the midst of the pandemic. The main challenges technology can address within insufficient patient enrollment, long clinical trial timelines due to inefficient data management, lack of evidence on patient outcomes, and low clinical trial success rate. TOP 5 REASONS TO ATTEND1- Executing adaptive trials to increase flexibility of clinical trials enabling parameters such as sample size, patient population, and dosing to be adjusted as the trial progresses2- Integrating a reimbursement strategy into the drug development strategy to collect evidence useful in negotiation with payers3- Improving the health of all people, widening data points, and improving customer experience by increasing diversity in clinical trials4- Leading the industry by engaging patients in Decentralized Clinical Trials to reduce the scheduling and travel burden on patients and expedite the trial5- Implementing AI and Machine Learning to positively transform your clinical trials Tickets https://go.evvnt.com/741411-2?pid=5569 Price:Pharmaceuticals/Medical Devices/Biotechnology USD 795.00 Time: On Wednesday April 28, 2021 at 9:00 am (ends Thursday April 29, 2021 at 4:20 pm)